Risk Factors for Venous Thromboembolism in Advanced Non-Small Cell Lung Cancer ― A Nationwide Administrative Database Study ―
Background: Non-small cell lung cancer (NSCLC) is associated with a high risk of venous thromboembolism (VTE). However, data on specific risk factors for VTE in patients with advanced NSCLC remain limited.
Authors
- Ayumi Shintani (ORCID: https://orcid.org/0000-0002-3323-110X)
- Yasutaka Ihara (ORCID: https://orcid.org/0000-0003-2538-6328)
- Megumi Mizutani
- Ryota Kawai (ORCID: https://orcid.org/0000-0003-3880-762X)
- Yugo Yamashita
- Tetsuya Kimura
Institutions
- Daiichi Sankyo (Germany) (DE)
- Kyoto University (JP)
- Daiichi Sankyo (United Kingdom) (GB)
- Ehime University Hospital (JP)
- Daiichi Sankyo (India) (IN)
- Universidad Metropolitana (VE)
- Daiichi Sankyo (United States) (US)
- Osaka Metropolitan University (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1253/circrep.cr-25-0167
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Bayer HealthCare
- Daiichi Sankyo Europe